| Multicentre trial to assess the performance of centralized assay solutions for detection of MTB and resistance to Rifampin and Isoniazid Evaluation of Centralised TB Assay Solutions (Phase 2) Protocol Version Number: v3.0 | Dr Sanghamitra Pati, Director, Regional Medical Research Centre (ICMR-RMRC), Orissa | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Tuberculosis |
| Phase-II Multicentric Clinical Study to Assess the Performance of the Xpert MTB/XDR Assay for INH and Second-Line Resistance Detection ? Xpert MTB/XDR Clinical Evaluation | Dr Vithal Prasad Myneedu, Microbiologist National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Tuberculosis |
| Multicentre trial to assess the performance of centralized assay solutions for detection of MTB and resistance to Rifampicin and Isoniazid | Dr Priya Rajendran, Scientist, National Institute for Research in Tuberculosis (ICMR-NIRT),Tamil Nadu | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Tuberculosis |
| Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities at Jan Swasthya Sahyog, Ganiyari, Chhattisgarh, India | Dr Gajanan Baburao Phutke, Junior Consultant, Jan Swasthya Sahyog (JSS), Chhattishgarh | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Antimicrobial Resistance |
| Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities in ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India | Dr Shanta Dutta, Director and Scientist, National Institute of Cholera & Enteric Diseases (ICMR-NICED), West Bengal | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Antimicrobial Resistance |
| Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities of R D Gardi Medical College, Ujjain, India | Dr Ashish Pathak, Professor, R D Gardi Medical College (RDGMC), Madhya Pradesh | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Antimicrobial Resistance |
| Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities in Civil Hospital, Manimajra, Chandigarh, North India | Dr Neelam Taneja, Professor, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Antimicrobial Resistance |
| Utility of multiplexed rapid fever panel kit among hospitalized febrile patients in India and its impact on antimicrobial use and diagnosis | Dr Pradeepy Michael Dcosta, Head of Department, King Edward Memorial Hospital Research Centre (KEMHRC), Maharashtra | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Antimicrobial Resistance |
| Pilot project to evaluate impact of a patient counseling and rehabilitation programme on treatment outcomes and quality of life in head and neck cancer patients receiving chemo radiotherapy | Dr Amit Bahl, Additional Professor, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | 2019 | American Society of Clinical Oncology (ASCO), USA | Oncology |
| To study the technical feasibility of endoscopic anterior screw fixation for the odontoid fracture | Dr Shweta Kedia, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2019 | Aospine Asia Pacific (AAP), Hong Kong | Basic Sciences |